Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in HIV Seropositivity: HELP
Oliver B. Laeyendecker
Based on 17 articles published since 2008
||||
Expertise Level
The expertise of Oliver B. Laeyendecker ranks in the
  • Top 0.12%
  • ... of 22,065 published authors worldwide on HIV Seropositivity
  • ... from 2008 through 2018
  • ... based on contributions to 17 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Laeyendecker, Oliver   ·   Laeyendecker, Oliver B
Work Locations
Details
Most likely:    National Institutes of Health      
2017
  • Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom. · Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom. · Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands. · Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom. · Stichting HIV Monitoring, Amsterdam, the Netherlands. · Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. · Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden. · Division for HIV and other Retroviruses, Robert Koch Institute, Berlin, Germany. · School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland. · Swiss Institute of Bioinformatics, Lausanne, Switzerland. · HIV/STI reference laboratory, WHO collaborating centre, Institute of Tropical Medicine, Department of Clinical Science, Antwerpen, Belgium. · Department of Infection and Population Health, University College London, London, United Kingdom. · Department of Epidemiology, John Hopkins University, Baltimore, Maryland, United States of America. · Department of Infectious Disease Epidemiology, Robert Koch-Institute, Berlin, Germany. · Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland. · Institute of Medical Virology, University of Zurich, Zurich, Switzerland. · Department of Infectious Diseases, Helsinki University Hospital, Helsinki, Finland. · Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Baltimore, Maryland, United States of America. · Department of Health Security, National Institute for Health and Welfare, Helsinki, Finland. · INSERM CESP U1018, Université Paris Sud, Université Paris Saclay, APHP, Service de Santé Publique, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France. · Virology Unit, Immunovirology Research Pole, Biomedical Sciences Department, Institute of Tropical Medicine, Antwerpen, Belgium. · Kymab Ltd, Cambridge, United Kingdom. · Division of Infectious Diseases, Department of Medicine, Imperial College London, London, United Kingdom. · Department of Global Health, Academic Medical Center, Amsterdam, the Netherlands. · Pubmed 28604782
2014
  • Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America. · Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America. · Rakai Health Sciences Program, Kalisizo, Uganda. · Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America; Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. · Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America. · School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. · Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America; Rakai Health Sciences Program, Kalisizo, Uganda; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. · Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America; Rakai Health Sciences Program, Kalisizo, Uganda; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. · Rakai Health Sciences Program, Kalisizo, Uganda; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. · Rakai Health Sciences Program, Kalisizo, Uganda; School of Public Health, College of Medicine, Makerere University, Kampala, Uganda. · Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America; Rakai Health Sciences Program, Kalisizo, Uganda. · Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. · Pubmed 24595023
2013
  • National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. · Pubmed 23129760
2012
  • Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. · Pubmed 22283149
  • National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 21205, USA. · Pubmed 22014036
2017
  • Departments of *Pathology; and †Medicine, Johns Hopkins University, School of Medicine, Baltimore, MD; ‡Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Baltimore, MD; §Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA; ‖Science Facilitation Department, FHI 360, Washington, DC; ¶Science Facilitation Department, FHI 360, Durham, NC; #UNC Project Laboratory, Tidziwe Centre, Kamuzu Central Hospital, Lilongwe, Malawi; **College of Medicine-Johns Hopkins Project, Blantyre, Malawi; ††Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC; ‡‡UNC Project-Malawi, Institute for Global Health and Infectious Diseases, Lilongwe, Malawi; §§Vaccine and Infectious Disease Division and Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA; and ‖‖Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC. · Pubmed 28471839
2012
  • Laboratory of Immunoregulation, NIAID, NIH, Bethesda, Maryland, USA. · Pubmed 21663455
Probable:    Johns Hopkins University   Contact    
2014
  • Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America. · Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America. · Rakai Health Sciences Program, Kalisizo, Uganda. · Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America; Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. · Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America. · School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. · Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America; Rakai Health Sciences Program, Kalisizo, Uganda; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. · Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America; Rakai Health Sciences Program, Kalisizo, Uganda; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. · Rakai Health Sciences Program, Kalisizo, Uganda; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. · Rakai Health Sciences Program, Kalisizo, Uganda; School of Public Health, College of Medicine, Makerere University, Kampala, Uganda. · Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America; Rakai Health Sciences Program, Kalisizo, Uganda. · Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. · Pubmed 24595023
2013
  • National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. · Pubmed 23129760
2012
  • Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. · Pubmed 22283149
  • National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 21205, USA. · Pubmed 22014036
2017
  • Departments of *Pathology; and †Medicine, Johns Hopkins University, School of Medicine, Baltimore, MD; ‡Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Baltimore, MD; §Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA; ‖Science Facilitation Department, FHI 360, Washington, DC; ¶Science Facilitation Department, FHI 360, Durham, NC; #UNC Project Laboratory, Tidziwe Centre, Kamuzu Central Hospital, Lilongwe, Malawi; **College of Medicine-Johns Hopkins Project, Blantyre, Malawi; ††Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC; ‡‡UNC Project-Malawi, Institute for Global Health and Infectious Diseases, Lilongwe, Malawi; §§Vaccine and Infectious Disease Division and Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA; and ‖‖Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC. · Pubmed 28471839
2013
  • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. · Pubmed 23129758
  • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Pubmed 23641870
2012
  • Johns Hopkins School of Medicine, Johns Hopkins Medical Institution, Baltimore, MD, USA. · Pubmed 21902588
2011
  • Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore Maryland, United States of America. · Pubmed 21298051
2010
  • Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. · Pubmed 20502314
2009
  • Department of Pathology, Johns Hopkins University School of Medicine, Maryland, USA. · Pubmed 19220138
2008
  • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. · Pubmed 18321879
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 17 total) written by Oliver B. Laeyendecker about HIV Seropositivity:

  • Brief Report: Impact of Early Antiretroviral Therapy on the Performance of HIV Rapid Tests and HIV Incidence Assays. 2017
  • Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe. 2017
  • The role of viral introductions in sustaining community-based HIV epidemics in rural Uganda: evidence from spatial clustering, phylogenetics, and egocentric transmission models. 2014
  • Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study. 2013
  • Cross-sectional HIV incidence estimation in HIV prevention research. 2013
  • Differential specificity of HIV incidence assays in HIV subtypes A and D-infected individuals from Rakai, Uganda. 2013
  • HIV incidence determination in the United States: a multiassay approach. 2013
  • Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries. 2012
  • Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay. 2012
  • Identification of new CRF51_01B in Singapore using full genome analysis of three HIV type 1 isolates. 2012
Show List of Full Article Records
Google Searches

Learn more about Oliver B. Laeyendecker using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
National Institutes of Health
Johns Hopkins University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
National Institutes of Health
2017
  • Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom. · Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom. · Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands. · Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom. · Stichting HIV Monitoring, Amsterdam, the Netherlands. · Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. · Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden. · Division for HIV and other Retroviruses, Robert Koch Institute, Berlin, Germany. · School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland. · Swiss Institute of Bioinformatics, Lausanne, Switzerland. · HIV/STI reference laboratory, WHO collaborating centre, Institute of Tropical Medicine, Department of Clinical Science, Antwerpen, Belgium. · Department of Infection and Population Health, University College London, London, United Kingdom. · Department of Epidemiology, John Hopkins University, Baltimore, Maryland, United States of America. · Department of Infectious Disease Epidemiology, Robert Koch-Institute, Berlin, Germany. · Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland. · Institute of Medical Virology, University of Zurich, Zurich, Switzerland. · Department of Infectious Diseases, Helsinki University Hospital, Helsinki, Finland. · Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Baltimore, Maryland, United States of America. · Department of Health Security, National Institute for Health and Welfare, Helsinki, Finland. · INSERM CESP U1018, Université Paris Sud, Université Paris Saclay, APHP, Service de Santé Publique, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France. · Virology Unit, Immunovirology Research Pole, Biomedical Sciences Department, Institute of Tropical Medicine, Antwerpen, Belgium. · Kymab Ltd, Cambridge, United Kingdom. · Division of Infectious Diseases, Department of Medicine, Imperial College London, London, United Kingdom. · Department of Global Health, Academic Medical Center, Amsterdam, the Netherlands. · Pubmed 28604782
2014
  • Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America. · Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America. · Rakai Health Sciences Program, Kalisizo, Uganda. · Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America; Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. · Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America. · School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. · Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America; Rakai Health Sciences Program, Kalisizo, Uganda; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. · Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America; Rakai Health Sciences Program, Kalisizo, Uganda; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. · Rakai Health Sciences Program, Kalisizo, Uganda; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. · Rakai Health Sciences Program, Kalisizo, Uganda; School of Public Health, College of Medicine, Makerere University, Kampala, Uganda. · Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America; Rakai Health Sciences Program, Kalisizo, Uganda. · Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. · Pubmed 24595023
2013
  • National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. · Pubmed 23129760
2012
  • Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. · Pubmed 22283149
  • National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 21205, USA. · Pubmed 22014036
2017
  • Departments of *Pathology; and †Medicine, Johns Hopkins University, School of Medicine, Baltimore, MD; ‡Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Baltimore, MD; §Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA; ‖Science Facilitation Department, FHI 360, Washington, DC; ¶Science Facilitation Department, FHI 360, Durham, NC; #UNC Project Laboratory, Tidziwe Centre, Kamuzu Central Hospital, Lilongwe, Malawi; **College of Medicine-Johns Hopkins Project, Blantyre, Malawi; ††Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC; ‡‡UNC Project-Malawi, Institute for Global Health and Infectious Diseases, Lilongwe, Malawi; §§Vaccine and Infectious Disease Division and Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA; and ‖‖Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC. · Pubmed 28471839
2012
  • Laboratory of Immunoregulation, NIAID, NIH, Bethesda, Maryland, USA. · Pubmed 21663455
Johns Hopkins University
2014
  • Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America. · Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America. · Rakai Health Sciences Program, Kalisizo, Uganda. · Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America; Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. · Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America. · School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. · Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America; Rakai Health Sciences Program, Kalisizo, Uganda; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. · Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America; Rakai Health Sciences Program, Kalisizo, Uganda; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. · Rakai Health Sciences Program, Kalisizo, Uganda; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. · Rakai Health Sciences Program, Kalisizo, Uganda; School of Public Health, College of Medicine, Makerere University, Kampala, Uganda. · Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America; Rakai Health Sciences Program, Kalisizo, Uganda. · Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America. · Pubmed 24595023
2013
  • National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. · Pubmed 23129760
2012
  • Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. · Pubmed 22283149
  • National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 21205, USA. · Pubmed 22014036
2017
  • Departments of *Pathology; and †Medicine, Johns Hopkins University, School of Medicine, Baltimore, MD; ‡Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Baltimore, MD; §Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA; ‖Science Facilitation Department, FHI 360, Washington, DC; ¶Science Facilitation Department, FHI 360, Durham, NC; #UNC Project Laboratory, Tidziwe Centre, Kamuzu Central Hospital, Lilongwe, Malawi; **College of Medicine-Johns Hopkins Project, Blantyre, Malawi; ††Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC; ‡‡UNC Project-Malawi, Institute for Global Health and Infectious Diseases, Lilongwe, Malawi; §§Vaccine and Infectious Disease Division and Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA; and ‖‖Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC. · Pubmed 28471839
2013
  • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. · Pubmed 23129758
  • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Pubmed 23641870
2012
  • Johns Hopkins School of Medicine, Johns Hopkins Medical Institution, Baltimore, MD, USA. · Pubmed 21902588
2011
  • Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore Maryland, United States of America. · Pubmed 21298051
2010
  • Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. · Pubmed 20502314
2009
  • Department of Pathology, Johns Hopkins University School of Medicine, Maryland, USA. · Pubmed 19220138
2008
  • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. · Pubmed 18321879
7 Other Locations Show
Yearly article counts 02001451112
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.